-
Forbes | A journalist walks into a lab, and less than 28 hours later has his bloodwork on his phone. Forbes contributor Dan Munro visited a Theranos lab inside a Phoenix Walgreens and takes the controversial clinical testing service for a ride
Jul 13, 2015
-
Diagnostics World | Earlier this month, Selventa published in BMC Medical Genomics the results of a study showing that their tool—ClarifyRA—identified nearly a third of patients who didn’t respond to anti-TNF treatment. Identifying non-responders will let those patients move on to second or third line therapies without a costly and painful trial and error period. It's an important step forward for company's model of systems diagnostics.
Jul 13, 2015
-
National Law Review | FDA plans to recognize "complementary diagnostics" as an additional category of tests to companion diagnostics.
Jul 10, 2015
-
Diagnostics World Product Brief | Definiens has launched Tissue Studio 4.1, offering faster throughput for tissue image analysis, powerful machine learning, and the ability to automate routine image analysis tasks, enabling researchers to develop a customized image analysis solution in as little as twenty minutes, and reduce preclinical safety and toxicity study lengths from weeks to just days.
Jul 8, 2015
-
Fortune | The FDA announced its approval of a Theranos test for the sexually transmitted disease herpes simplex virus (HSV-1) and--more importantly--approval for the Theranos platform.
Jul 2, 2015
-
Xconomy | Natera's IPO is looming, with the offering coming as early as tonight. Xconomy reports that in documents filed today with the SEC, the company raised its fundraising goal to $175 million. The company hopes to sell 10 million shares at $17-$18 each.
Jul 1, 2015
-
Diagnostics World Brief | In a new market report released this morning, BCC Research predicts the next-generation sequencing (NGS) clinical market could grow at a compound annual growth rate of 31.3% from $997.1m in 2015 to nearly $3.9b by 2020.
Jul 1, 2015
-
Technology Review | Eventually, the most important use of liquid biopsies should be to catch signs of cancer early, before symptoms arise—when a surgeon can cure it by cutting it out. Such screening could profoundly reshape cancer medicine. For now, though, they are being used as “theragnostics”—that is, tests that guide decisions about treatment.
Jun 25, 2015
-
Diagnostics World | Color Genomics is just one of several companies toying with a new model for selling low-priced DNA tests online, by enlisting physicians as intermediaries. If Color's business model becomes popular, it will have big implications for the way genomic testing reaches the broader public — and who sets the standards for this maturing technology.
Jun 22, 2015
-
Diagnostics World Brief | Foundation Medicine has launched PatientMatch, a tool to connect doctors who are treating patients with similar rare genetic mutations. At Sarah Cannon Research Institute, physicians are finding it useful for connecting patients to the right drug trials as well.
Jun 22, 2015
-
Diagnostics World Brief | The human body is host to an astonishing array of viruses, but efforts to study this secretive population have hit technological limitations. At Brigham & Women's Hospital in Boston, a new blood test is letting researchers look at patients' whole histories of viral infection, using their antibodies as a permanent record.
Jun 22, 2015
-
Diagnostics World Brief | Invitae Corporation today announced a patient pay price for its full menu of genetic tests. For $475 per indication, patients can pay for their own genetic tests if insurance coverage is not available. The price covers all of Invitae’s offerings in cancer, cardiology, neurology, pediatric genetics, hematology and other rare conditions
Jun 22, 2015
-
Diagnostics World Brief | Definiens today launched a new suite of Biomarker Datafication Services for oncology clinical development programs. The package provides image analysis screening of tissue samples for exploratory screening, pharmacokinetics/pharmacodynamics, and companion diagnostic development.
Jun 22, 2015
-
Diagnostics World Brief | Strand Life Sciences announced an expanded StrandAdvantage pan cancer genomic profiling service. The new version of StrandAdvantage will include a panel that examines 152 genes and pathways known to be impacted by existing targeted solid tumor therapies.
Jun 1, 2015
-
By Bio IT World Staff March 30, 2015 | The New York Genome Center (NYGC) announced today that it has received approval from the New York State Department of Health to offer clinical whole exome sequencing for individuals with constitutional disorders.
May 27, 2015
-
By Bio IT World Staff April 13, 2015 | Roche is at it again. The pharma today acquired CAPP Medical, a genomics research company founded by Stanford University oncologists and industry veterans, to advance the development of technology for cancer screening
May 27, 2015
-
May 14, 2015 | Mayo Clinic in Rochester, Minn., has announced plans to sequence genes from 10,000 patients for genetic variants that could affect their responses to a variety of medications, as part of a study that will track the long
May 27, 2015
-
By Bio IT World Staff May 27, 2015 | Yesterday afternoon QIAGEN announced the commercial launch of QIAGEN Clinical Insight (QCI), a bioinformatics content and software platform for clinical testing labs to interpret and report on genomic variants identified in next
May 27, 2015